BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 24351288)

  • 21. Distinct pattern of TP53 mutations in human immunodeficiency virus-related head and neck squamous cell carcinoma.
    Gleber-Netto FO; Zhao M; Trivedi S; Wang J; Jasser S; McDowell C; Kadara H; Zhang J; Wang J; William WN; Lee JJ; Nguyen ML; Pai SI; Walline HM; Shin DM; Ferris RL; Carey TE; Myers JN; Pickering CR;
    Cancer; 2018 Jan; 124(1):84-94. PubMed ID: 29053175
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comprehensive genomic profiling of head and neck squamous cell carcinoma reveals FGFR1 amplifications and tumour genomic alterations burden as prognostic biomarkers of survival.
    Dubot C; Bernard V; Sablin MP; Vacher S; Chemlali W; Schnitzler A; Pierron G; Ait Rais K; Bessoltane N; Jeannot E; Klijanienko J; Mariani O; Jouffroy T; Calugaru V; Hoffmann C; Lesnik M; Badois N; Berger F; Le Tourneau C; Kamal M; Bieche I
    Eur J Cancer; 2018 Mar; 91():47-55. PubMed ID: 29331751
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NOTCH1 Signaling in Head and Neck Squamous Cell Carcinoma.
    Shah PA; Huang C; Li Q; Kazi SA; Byers LA; Wang J; Johnson FM; Frederick MJ
    Cells; 2020 Dec; 9(12):. PubMed ID: 33322834
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High NOTCH1 mRNA Expression Is Associated with Better Survival in HNSCC.
    Wirth M; Jira D; Ott A; Piontek G; Pickhard A
    Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29533972
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Somatic Mutations and Genetic Variants of NOTCH1 in Head and Neck Squamous Cell Carcinoma Occurrence and Development.
    Liu YF; Chiang SL; Lin CY; Chang JG; Chung CM; Ko AM; Lin YZ; Lee CH; Lee KW; Chen MK; Hua CH; Tsai MH; Chen YC; Ko YC
    Sci Rep; 2016 Apr; 6():24014. PubMed ID: 27035284
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The
    Fukusumi T; Guo TW; Sakai A; Ando M; Ren S; Haft S; Liu C; Amornphimoltham P; Gutkind JS; Califano JA
    Clin Cancer Res; 2018 Feb; 24(3):619-633. PubMed ID: 29146722
    [No Abstract]   [Full Text] [Related]  

  • 27. Integrative genetic, epigenetic and pathological analysis of paraganglioma reveals complex dysregulation of NOTCH signaling.
    Cama A; Verginelli F; Lotti LV; Napolitano F; Morgano A; D'Orazio A; Vacca M; Perconti S; Pepe F; Romani F; Vitullo F; di Lella F; Visone R; Mannelli M; Neumann HP; Raiconi G; Paties C; Moschetta A; Tagliaferri R; Veronese A; Sanna M; Mariani-Costantini R
    Acta Neuropathol; 2013 Oct; 126(4):575-94. PubMed ID: 23955600
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gene-expression signature regulated by the KEAP1-NRF2-CUL3 axis is associated with a poor prognosis in head and neck squamous cell cancer.
    Namani A; Matiur Rahaman M; Chen M; Tang X
    BMC Cancer; 2018 Jan; 18(1):46. PubMed ID: 29306329
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic significance of the methylation of Wnt pathway antagonists-CXXC4, DACT2, and the inhibitors of sonic hedgehog signaling-ZIC1, ZIC4, and HHIP in head and neck squamous cell carcinomas.
    Paluszczak J; Wiśniewska D; Kostrzewska-Poczekaj M; Kiwerska K; Grénman R; Mielcarek-Kuchta D; Jarmuż-Szymczak M
    Clin Oral Investig; 2017 Jun; 21(5):1777-1788. PubMed ID: 27553089
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incorporation of Next-Generation Sequencing into Routine Clinical Care to Direct Treatment of Head and Neck Squamous Cell Carcinoma.
    Chau NG; Li YY; Jo VY; Rabinowits G; Lorch JH; Tishler RB; Margalit DN; Schoenfeld JD; Annino DJ; Goguen LA; Thomas T; Becker H; Haddad T; Krane JF; Lindeman NI; Shapiro GI; Haddad RI; Hammerman PS
    Clin Cancer Res; 2016 Jun; 22(12):2939-49. PubMed ID: 26763254
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of high levels of Jagged-1 and Notch-1 expression with poor prognosis in head and neck cancer.
    Lin JT; Chen MK; Yeh KT; Chang CS; Chang TH; Lin CY; Wu YC; Su BW; Lee KD; Chang PJ
    Ann Surg Oncol; 2010 Nov; 17(11):2976-83. PubMed ID: 20517681
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The opposing roles of NOTCH signalling in head and neck cancer: a mini review.
    Yap LF; Lee D; Khairuddin A; Pairan MF; Puspita B; Siar CH; Paterson IC
    Oral Dis; 2015 Oct; 21(7):850-7. PubMed ID: 25580884
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preferential activation of the hedgehog pathway by epigenetic modulations in HPV negative HNSCC identified with meta-pathway analysis.
    Fertig EJ; Markovic A; Danilova LV; Gaykalova DA; Cope L; Chung CH; Ochs MF; Califano JA
    PLoS One; 2013; 8(11):e78127. PubMed ID: 24223768
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alterations of Notch pathway in patients with adenoid cystic carcinoma of the trachea and its impact on survival.
    Xie M; Wei S; Wu X; Li X; You Y; He C
    Lung Cancer; 2018 Jul; 121():41-47. PubMed ID: 29858025
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Frequent promoter hypermethylation of PTPRT increases STAT3 activation and sensitivity to STAT3 inhibition in head and neck cancer.
    Peyser ND; Freilino M; Wang L; Zeng Y; Li H; Johnson DE; Grandis JR
    Oncogene; 2016 Mar; 35(9):1163-9. PubMed ID: 25982282
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Copy number amplification of the PIK3CA gene is associated with poor prognosis in non-lymph node metastatic head and neck squamous cell carcinoma.
    Suda T; Hama T; Kondo S; Yuza Y; Yoshikawa M; Urashima M; Kato T; Moriyama H
    BMC Cancer; 2012 Sep; 12():416. PubMed ID: 22994622
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Frequently methylated tumor suppressor genes in head and neck squamous cell carcinoma.
    Bennett KL; Karpenko M; Lin MT; Claus R; Arab K; Dyckhoff G; Plinkert P; Herpel E; Smiraglia D; Plass C
    Cancer Res; 2008 Jun; 68(12):4494-9. PubMed ID: 18559491
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Doublecortin-Like Kinase 1 (DCLK1) Is a Novel NOTCH Pathway Signaling Regulator in Head and Neck Squamous Cell Carcinoma.
    Broner EC; Trujillo JA; Korzinkin M; Subbannayya T; Agrawal N; Ozerov IV; Zhavoronkov A; Rooper L; Kotlov N; Shen L; Pearson AT; Rosenberg AJ; Savage PA; Mishra V; Chatterjee A; Sidransky D; Izumchenko E
    Front Oncol; 2021; 11():677051. PubMed ID: 34336664
    [TBL] [Abstract][Full Text] [Related]  

  • 39. γ-Secretase inhibitor reduces immunosuppressive cells and enhances tumour immunity in head and neck squamous cell carcinoma.
    Mao L; Zhao ZL; Yu GT; Wu L; Deng WW; Li YC; Liu JF; Bu LL; Liu B; Kulkarni AB; Zhang WF; Zhang L; Sun ZJ
    Int J Cancer; 2018 Mar; 142(5):999-1009. PubMed ID: 29047105
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sequencing the head and neck cancer genome: implications for therapy.
    Sun W; Califano JA
    Ann N Y Acad Sci; 2014 Dec; 1333():33-42. PubMed ID: 25440877
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.